Genome-wide association analysis of age at onset in schizophrenia in a European-American sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 6, 2011, Pages 671-680

  Wang, Ke Sheng ^a   Liu, Xuefeng ^a   Zhang, Qunyuan ^b   Aragam, Nagesh ^a   Pan, Yue ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age at onset; Gene gender interaction; Genome wide association; Haplotype; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 4; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; CHROMOSOMES, HUMAN, PAIR 4; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; NON-FIBRILLAR COLLAGENS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX FACTORS;

EID: 80051559269     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31209     Document Type: Article

References (86)

1. Aberg K, Axelsson E, Saetre P, Jiang L, Wetterberg L, Pettersson U, Lindholm E, Jazin E. 2008. Support for schizophrenia susceptibility locus on chromosome 2q detected in a Swedish isolate using a dense map of microsatellites and SNPs. Am J Med Genet Part B 147B(7): 1238-1244.
2. Alaerts M, Del-Favero J. 2009. Searching genetic risk factors for schizophrenia and bipolar disorder: Learn from the past and back to the future. Hum Mutat 30(8): 1139-1152.
3. Albus M, Maier W. 1995. Lack of gender differences in age at onset in familial schizophrenia. Schizophr Res 18(1): 51-57.
4. Anttila S, Kampman O, Illi A, Roivas M, Mattila KM, Lassila V, Lehtimaki T, Leinonen E. 2003. NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia. Psychiatr Genet 13(2): 61-64.
5. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
6. Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, Turrini P, Thiene G, Danieli GA, Nava A. 2002. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J Am Coll Cardiol 40(2): 341-349.
7. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, et al. 1998. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20(1): 70-73.
8. Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon MR, Thiery J, Bluher M, Stumvoll M, Kovacs P. 2006. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 91(7): 2725-2731.
9. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. 1998. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55(1): 67-74.
10. Cardno AG, Holmans PA, Rees MI, Jones LA, McCarthy GM, Hamshere ML, Williams NM, Norton N, Williams HJ, Fenton I, et al. 2001. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet 105(5): 439-445.
11. Carroll LS, Owen MJ. 2009. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 1(10): 102.
12. Comabella M, Craig DW, Morcillo-Suarez C, Rio J, Navarro A, Fernandez M, Martin R, Montalban X. 2009. Genome-wide scan of 500, 000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. Arch Neurol 66(8): 972-978.
13. Danese A. 2006. A public health genetic approach for schizophrenia. Epidemiol Psichiatrry Soc 15(3): 185-193.
14. DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, et al. 2002. PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study. Am J Hum Genet 70(5): 1089-1095.
15. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66(2): 87-98.
16. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, Juvonen H, Varilo T, Arajarvi R, Kokko-Sahin ML, et al. 2000. Genome-wide scan for schizophrenia in the Finnish population: Evidence for a locus on chromosome 7q22. Hum Mol Genet 9(7): 1049-1057.
17. Fanous AH, Neale MC, Webb BT, Straub RE, Amdur RL, O'Neill FA, Walsh D, Riley BP, Kendler KS. 2007. A genome-wide scan for modifier loci in schizophrenia. Am J Med Genet Part B 144B(5): 589-595.
18. Faraone SV, Chen WJ, Goldstein JM, Tsuang MT. 1994. Gender differences in age at onset of schizophrenia. Br J Psychiatry 164(5): 625-629.
19. Fava D, Gardner S, Pyke D, Leslie RD. 1998. Evidence that the age at diagnosis of IDDM is genetically determined. Diabetes Care 21(6): 925-929.
20. Folnegovic Z, Folnegovic-Smalc V. 1994. Schizophrenia in Croatia: Age of onset differences between males and females. Schizophr Res 14(1): 83-91.
21. Forsell C, Bjork BF, Lilius L, Axelman K, Fabre SF, Fratiglioni L, Winblad B, Graff C. 2010. Genetic association to the amyloid plaque associated protein gene COL25A1 in Alzheimer's disease. Neurobiol Aging 31(3): 409-415.
22. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, 2006.
23. Gejman PV, Sanders AR, Duan J. 2010. The role of genetics in the etiology of schizophrenia. Psychiatr Clin North Am 33(1): 35-66.
24. Gottesman II, Shields J. 1982. Schizophrenia: The epigenetic puzzle. Cambridge, UK: Cambridge University Press.
25. Guessous I, Gwinn M, Khoury MJ. 2009. Genome-wide association studies in pharmacogenomics: Untapped potential for translation. Genome Med 1(4): 46.
26. Hafner H, Fatkenheuer B, an der Heiden W, Loffler W, Maurer K, Munk-Jorgensen P, Riecher A. 1991. Sex differences in age of onset, symptomatology and evolution of schizophrenia. Sante Ment Que 16(1): 77-98.
27. Hafner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Loffler W, Maurer K, Munk-Jorgensen P, Nowotny B, Riecher-Rossler A, et al. 1998. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 24(1): 99-113.
28. Hare E, Glahn DC, Dassori A, Raventos H, Nicolini H, Ontiveros A, Medina R, Mendoza R, Jerez A, Munoz R, et al. 2010. Heritability of age of onset of psychosis in schizophrenia. Am J Med Genet Part B 153B(1): 298-302.
29. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, Kelsoe J, Fitzgerald M, Gill M. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8(3): 299-308.
30. Holmans PA, Riley B, Pulver AE, Owen MJ, Wildenauer DB, Gejman PV, Mowry BJ, Laurent C, Kendler KS, Nestadt G, et al. 2009. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry 14(8): 786-795.
31. Jiang D, Wang R, Xiao B, Kong H, Hunt DJ, Choi P, Zhang L, Chen SR. 2005. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 97(11): 1173-1181.
32. Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E, Lehtimaki T. 2004. Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. J Hum Genet 49(7): 355-359.
33. Karayiorgou M, Gogos JA. 1997. A turning point in schizophrenia genetics. Neuron 19(5): 967-979.
34. Karayiorgou M, Gogos JA. 2006. Schizophrenia genetics: Uncovering positional candidate genes. Eur J Hum Genet 14(5): 512-519.
35. Kendler KS, Walsh D. 1995. Gender and schizophrenia. Results of an epidemiologically-based family study. Br J Psychiatry 167(2): 184-192.
36. Kendler KS, Tsuang MT, Hays P. 1987. Age at onset in schizophrenia. A familial perspective. Arch Gen Psychiatry 44(10): 881-890.
37. Kendler KS, Karkowski-Shuman L, O'Neill FA, Straub RE, MacLean CJ, Walsh D. 1997. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity. Am J Psychiatry 154(2): 191-198.
38. Kile BT, Panopoulos AD, Stirzaker RA, Hacking DF, Tahtamouni LH, Willson TA, Mielke LA, Henley KJ, Zhang JG, Wicks IP, et al. 2007. Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia. Blood 110(7): 2371-2380.
39. Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF, Sokoloff P. 2000. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 5(5): 558-562.
40. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, et al. 2001. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103(4): 485-490.
41. Le Hellard S, Lee AJ, Underwood S, Thomson PA, Morris SW, Torrance HS, Anderson SM, Adams RR, Navarro P, Christoforou A, et al. 2007. Haplotype analysis and a novel allele-sharing method refines a chromosome 4p locus linked to bipolar affective disorder. Biol Psychiatry 61(6): 797-805.
42. Leboyer M, Filteau MJ, Jay M, Campion D, d'Amato T, Guilloud-Bataille M, Hillaire D, Feingold J, des Lauriers A, Widlocher D. 1992a. Clinical subtypes and age at onset in schizophrenic siblings. Psychiatr Res 41(2): 107-114.
43. Leboyer M, Filteau MJ, Jay M, Campion D, Rochet T, D'Amato T, Feingold J, Des Lauriers A, Widlocher D. 1992b. No gender effect on age at onset in familial schizophrenia? Am J Psychiatry 149(10): 1409.
44. Lee KY, Ahn YM, Joo EJ, Joo YH, Chang JS, Yoo HY, Kim YS. 2006. Partial evidence of an association between epidermal growth factor A61G polymorphism and age at onset in male schizophrenia. Neurosci Res 56(4): 356-362.
45. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, et al. 2002. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4): 985-993.
46. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373(9659): 234-239.
47. Loranger AW. 1984. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 41(2): 157-161.
48. Mahon PB, Pirooznia M, Goes FS, Seifuddin F, Steele J, Lee PH, Huang J, Hamshere ML, The Bipolar Genome Study (BiGS) Consortium, The Wellcome Trust Case Control Consortium Bipolar Disorder Group, Depaulo JR Jr, Kelsoe JR, Rietschel M, Nöthen M, Cichon S, Gurling H, Purcell S, Smoller JW, Craddock N, Schulze TG, McMahon FJ, Potash JB, Zandi PP, 2011. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder. Am J Med Genet Part B 88(3): 372-381.
49. Mazaki-Tovi S, Vaisbuch E, Romero R, Kusanovic JP, Chaiworapongsa T, Kim SK, Nhan-Chang CL, Gomez R, Yoon BH, Yeo L, et al. 2010. Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis. Am J Reprod Immunol 63(3): 252-262.
50. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. 2008. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 9(5): 356-369.
51. Mehler-Wex C, Riederer P, Gerlach M. 2006. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 10(3-4): 167-179.
52. Muir WJ, Thomson ML, McKeon P, Mynett-Johnson L, Whitton C, Evans KL, Porteous DJ, Blackwood DH. 2001. Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am J Med Genet 105(2): 152-158.
53. Nadalin S, Rubesa G, Giacometti J, Vulin M, Tomljanovic D, Vranekovic J, Kapovic M, Buretic-Tomljanovic A. 2008. BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder. Prostaglandins Leukot Essent Fatty Acids 78(6): 351-360.
54. Naqvi H, Khan MM, Faizi A. 2005. Gender differences in age at onset of schizophrenia. J Coll Physicians Surg Pak 15(6): 345-348.
55. Nieratschker V, Nothen MM, Rietschel M. 2010. New genetic findings in schizophrenia: Is there still room for the dopamine hypothesis of schizophrenia? Front Behav Neurosci 4: 23.
56. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40(9): 1053-1055.
57. Ohi K, Hashimoto R, Yasuda Y, Kiribayashi M, Iike N, Yoshida T, Azechi M, Ikezawa K, Takahashi H, Morihara T, et al. 2009. TATA box-binding protein gene is associated with risk for schizophrenia, age at onset and prefrontal function. Genes Brain Behav 8(4): 473-480.
58. Osada Y, Hashimoto T, Nishimura A, Matsuo Y, Wakabayashi T, Iwatsubo T. 2005. CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils. J Biol Chem 280(9): 8596-8605.
59. Owen MJ, Williams HJ, O'Donovan MC. 2009. Schizophrenia genetics: Advancing on two fronts. Curr Opin Genet Dev 19(3): 266-270.
60. Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, Nee J, Grunn A, Kanyas K, Lerer B, et al. 2004. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 9(12): 1091-1099.
61. Paschou P, Kukuvitis A, Yavropoulou MP, Dritsoula A, Giapoutzidis V, Anastasiou O, Kazakos K, Yovos JG. 2010. Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population. Cytokine 51(1): 25-27.
62. Pilz S, Mangge H, Obermayer-Pietsch B, Marz W. 2007. Visfatin/pre-B-cell colony-enhancing factor: A protein with various suggested functions. J Endocrinol Invest 30(2): 138-144.
63. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8): 904-909.
64. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
65. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, et al. 2008. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics. Am J Psychiatry 165(4): 497-506.
66. Sherrington R, Mankoo B, Attwood J, Kalsi G, Curtis D, Buetow K, Povey S, Gurling H. 1993. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. Genomics 18(2): 423-425.
67. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460(7256): 753-757.
68. Shirasawa S, Harada H, Furugaki K, Akamizu T, Ishikawa N, Ito K, Tamai H, Kuma K, Kubota S, Hiratani H, et al. 2004. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 13(19): 2221-2231.
69. Stober G, Franzek E, Haubitz I, Pfuhlmann B, Beckmann H. 1998. Gender differences and age of onset in the catatonic subtypes of schizophrenia. Psychopathology 31(6): 307-312.
70. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12): 1187-1192.
71. Suvisaari JM, Haukka J, Tanskanen A, Lonnqvist JK. 1998. Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br J Psychiatry 173: 494-500.
72. Takahashi S, Matsuura M, Tanabe E, Yara K, Nonaka K, Fukura Y, Kikuchi M, Kojima T. 2000. Age at onset of schizophrenia: Gender differences and influence of temporal socioeconomic change. Psychiatr Clin Neurosci 54(2): 153-156.
73. Takase K, Ohtsuki T, Migita O, Toru M, Inada T, Yamakawa-Kobayashi K, Arinami T. 2001. Association of ZNF74 gene genotypes with age-at-onset of schizophrenia. Schizophr Res 52(3): 161-165.
74. Takeuchi F, Nabika T, Isono M, Katsuya T, Sugiyama T, Yamaguchi S, Kobayashi S, Yamori Y, Ogihara T, Kato N. 2009. Evaluation of genetic loci influencing adult height in the Japanese population. J Hum Genet 54(12): 749-752.
75. Tang YL, Gillespie CF, Epstein MP, Mao PX, Jiang F, Chen Q, Cai ZJ, Mitchell PB. 2007. Gender differences in 542 Chinese inpatients with schizophrenia. Schizophr Res 97(1-3): 88-96.
76. Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen T, Krarup G, Jorgensen P, Nordentoft M. 2007. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis 195(5): 396-405.
77. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, et al. 2001. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10(3): 189-194.
78. Tong Y, Xu Y, Scearce-Levie K, Ptacek LJ, Fu YH. 2010. COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenetics 11(1): 41-52.
79. Tsai SJ, Hong CJ, Liao DL, Lai IC, Liou YJ. 2004. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49(4): 196-200.
80. Unluturk U, Harmanci A, Yildiz BO, Bayraktar M. 2010. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women. Clin Endocrinol (Oxf) 72(4): 469-474.
81. Vares M, Saetre P, Deng H, Cai G, Liu X, Hansen T, Rasmussen HB, Werge T, Melle I, Djurovic S, et al. 2010. Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia. Am J Med Genet Part B 153B(2): 610-618.
82. Venkatesh BK, Thirthalli J, Naveen MN, Kishorekumar KV, Arunachala U, Venkatasubramanian G, Subbakrishna DK, Gangadhar BN. 2008. Sex difference in age of onset of schizophrenia: Findings from a community-based study in India. World Psychiatry 7(3): 173-176.
83. Walss-Bass C, Montero AP, Armas R, Dassori A, Contreras SA, Liu W, Medina R, Levinson D, Pereira M, Atmella I, et al. 2006. Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3. Psychiatr Genet 16(4): 159-168.
84. Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkila K, Suvisaari J, Partonen T, et al. 2008. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry 13(7): 673-684.
85. Williams NM, Cardno AG, Murphy KC, Jones LA, Asherson P, McGuffin P, Owen MJ. 1997. Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene. Psychiatr Genet 7(2): 83-85.
86. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447(7145): 661-678.